CERENIA DIN 02299542
Status: Marketed
Holder: ZOETIS CANADA INC
Molecule: MAROPITANT (MAROPITANT CITRATE)
Available to quote
Health Canada record
| Active ingredient(s) | MAROPITANT (MAROPITANT CITRATE) 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 17-Jan-2008 |
| Current status date | 03-Apr-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MAROPITANT (MAROPITANT CITRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02299518 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02299526 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
| 02299534 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02299496 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
| 02568527 | ELMARO | ELANCO CANADA LIMITED | Solution | MAROPITANT (MAROPITANT CITRATE) 10 MG | Approved |
| 02561379 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02561360 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
| 02561387 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
| 02561395 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02557916 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Approved |
| 02557894 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Approved |
| 02557924 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Approved |
| 02557908 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Approved |
| 02561077 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
| 02561107 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02561085 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02561093 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22317 | 2019-06-25 | Supplement to a New Drug Submission (SNDS) | ADDITION OF MANUFACTURING SITE |
| 18330 | 2016-08-04 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAIMS, ADDITIONAL ROUTE OF ADMINISTRATION (INTRAVENOUS) |
| 14977 | 2012-12-03 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER |
| 13865 | 2012-11-22 | Supplement to a New Drug Submission (SNDS) | Change to Dosage and ADministration. |
| 13863 | 2012-11-22 | Supplement to a New Drug Submission (SNDS) | Additional species |
| 9034 | 2007-09-20 | New Drug Submission (NDS) |